Selective inhibition of brain endothelial Rho-kinase-2 provides optimal protection of an in vitro blood-brain barrier from tissue-type plasminogen activator and plasmin

PloS One
Be'eri NiegoRobert L Medcalf

Abstract

Rho-kinase (ROCK) inhibition, broadly utilised in cardiovascular disease, may protect the blood-brain barrier (BBB) during thrombolysis from rt-PA-induced damage. While the use of nonselective ROCK inhibitors like fasudil together with rt-PA may be hindered by possible hypotensive side-effects and inadequate capacity to block detrimental rt-PA activity in brain endothelial cells (BECs), selective ROCK-2 inhibition may overcome these limitations. Here, we examined ROCK-2 expression in major brain cells and compared the ability of fasudil and KD025, a selective ROCK-2 inhibitor, to attenuate rt-PA-induced BBB impairment in an in vitro human model. ROCK-2 was highly expressed relative to ROCK-1 in all human and mouse brain cell types and particularly enriched in rodent brain endothelial cells and astrocytes compared to neurons. KD025 was more potent than fasudil in attenuation of rt-PA- and plasminogen-induced BBB permeation under normoxia, but especially under stroke-like conditions. Importantly, only KD025, but not fasudil, was able to block rt-PA-dependent permeability increases, morphology changes and tight junction degradation in isolated BECs. Selective ROCK-2 inhibition further diminished rt-PA-triggered myosin phosphorylat...Continue Reading

References

Feb 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·E O MajorJ Sever
Jun 5, 2003·Nature Reviews. Molecular Cell Biology·Kirsi Riento, Anne J Ridley
Oct 25, 2003·Journal of Cell Science·Svetlana M StamatovicAnuska V Andjelkovic
Apr 21, 2005·Thrombosis and Haemostasis·Jerry P Melchor, Sidney Strickland
Jul 9, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Hiroaki Shimokawa, Akira Takeshita
Jul 12, 2005·Journal of the Neurological Sciences·Masato ShibuyaUNKNOWN Fasudil Ischemic Stroke Study Group
Sep 6, 2005·Stroke; a Journal of Cerebral Circulation·Yoshiyuki RikitakeJames K Liao
Jun 3, 2006·Stroke; a Journal of Cerebral Circulation·Sophia WangEng H Lo
Oct 13, 2006·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Hwa Kyoung ShinCenk Ayata
Oct 4, 2008·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Marjan BoermaMartin Hauer-Jensen
Feb 10, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Phyllus Y Mong, Qin Wang
Apr 20, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Brad A BryanPatricia A D'Amore
Jul 24, 2010·Stroke; a Journal of Cerebral Circulation·Claire AllenUlvi Bayraktutan
Feb 18, 2011·Pediatric Cardiology·Jianjian ShiLei Wei
May 23, 2012·Journal of cardiology·Kensuke NomaYukihito Higashi
Sep 19, 2012·Cell Structure and Function·Michiro IizukaAkira Mizoguchi
Feb 9, 2013·Cell Death & Disease·Jianjian ShiLei Wei
Feb 12, 2013·CNS & Neurological Disorders Drug Targets·Joyce S BalamiAlastair M Buchan
Feb 23, 2013·Pathology Research International·André R GreenidgeR Clive Landis
Jan 28, 2014·Annals of Clinical and Translational Neurology·Jeong Hyun LeeCenk Ayata
Jun 5, 2014·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Be'eri Niego, Robert L Medcalf
Nov 12, 2014·Proceedings of the National Academy of Sciences of the United States of America·Alexandra Zanin-ZhorovSamuel D Waksal
Apr 15, 2015·Vascular Pharmacology·Cora M L BeckersGeerten P van Nieuw Amerongen
Jun 17, 2015·Pharmacology & Therapeutics·Antonio MorettiRoberto F Villa
Jul 15, 2015·The Journal of Cell Biology·Karen A Newell-LitwaAlan Rick Horwitz
Dec 5, 2015·Frontiers in Pharmacology·Svenja HartmannSusanne Lutz
Jul 20, 2016·Hypertension·T Michael De SilvaFrank M Faraci

❮ Previous
Next ❯

Citations

Jul 18, 2018·Annals of Neurology·Homa SadeghianCenk Ayata
Jun 22, 2018·Arthritis & Rheumatology·John G HanlyJulius Birnbaum
Sep 3, 2019·Frontiers in Neurology·Şefik Evren Erdener, Turgay Dalkara
Jun 22, 2018·Annals of Clinical and Translational Neurology·Murtaza AkhterCenk Ayata
Jul 1, 2020·Neural Regeneration Research·George Zaki Ghali, Michael George Zaki Ghali
Sep 20, 2017·Journal of Thrombosis and Haemostasis : JTH·R L Medcalf
Sep 13, 2019·Arteriosclerosis, Thrombosis, and Vascular Biology·Anuska V AndjelkovicRichard F Keep
Jul 31, 2019·Computational and Structural Biotechnology Journal·Jan MicanJiri Damborsky
Sep 14, 2021·Journal of the American Heart Association·Martin EzeaniBe'eri Niego

❮ Previous
Next ❯

Datasets Mentioned

BETA
GM6001

Methods Mentioned

BETA
GTPase
PCR
Assay
electrophoresis
dissection

Software Mentioned

GraphPad Prism
Nikon NIS - Elements
ARRIVE
Plgn
ImageJ

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Blood Brain Barrier & Cytokines

Some cytokines are able to cross the blood brain barrier through transport systems and enter the cerebrospinal fluid and interstitial fluid spaces. Here is the latest research on cytokines crossing the blood brain barrier and how this can affect tissues within the CNS.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Acute Stroke

A stroke occurs when blood supply to the brain is interrupted depriving the brain of oxygen and nutrients. This feed focuses cerebrovascular accidents including ischemic and paralytic stroke.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
Be'eri Niego, Robert L Medcalf
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
K D MullenA J McCullough
© 2022 Meta ULC. All rights reserved